Anne Negard

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

MRI versus histopathology in EMVI detection for rectal cancer: prognostic relevance and survival outcomes.

MRI versus histopathology in EMVI detection for rectal cancer: prognostic relevance and survival outcomes.

Journal: European radiology

Published: January 31, 2026

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

Journal: ImmunoTargets and therapy

Published: January 09, 2026

Intra- and interobserver variability in renal multiparametric magnetic resonance imaging: T1 mapping, diffusion-weighted imaging, arterial spin labeling, blood oxygen level-dependent and renal artery flow measurements utilizing manual segmentation.

Intra- and interobserver variability in renal multiparametric magnetic resonance imaging: T1 mapping, diffusion-weighted imaging, arterial spin labeling, blood oxygen level-dependent and renal artery flow measurements utilizing manual segmentation.

Journal: Quantitative imaging in medicine and surgery

Published: December 16, 2025

Agreement of axial T2-MRI versus Contrast-Enhanced CT for solid renal mass active surveillance.

Agreement of axial T2-MRI versus Contrast-Enhanced CT for solid renal mass active surveillance.

Journal: Abdominal radiology (New York)

Published: November 01, 2025

Agreement between Routine-Dose and Lower-Dose CT with and without Deep Learning-based Denoising for Active Surveillance of Solid Small Renal Masses: A Multiobserver Study.

Agreement between Routine-Dose and Lower-Dose CT with and without Deep Learning-based Denoising for Active Surveillance of Solid Small Renal Masses: A Multiobserver Study.

Journal: Radiology. Imaging cancer

Published: June 13, 2025

Low b-values in apparent diffusion coefficient calculations overestimate diffusion in rectal cancer.

Low b-values in apparent diffusion coefficient calculations overestimate diffusion in rectal cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 31, 2025

Bisacodyl micro-enema before MRI of rectal tumors: effects on rectum, image quality and patient acceptance.

Bisacodyl micro-enema before MRI of rectal tumors: effects on rectum, image quality and patient acceptance.

Journal: European radiology

Published: May 20, 2025

Dissemination of Mitochondrial DNA Variants: Looking at the 'Bigger' Picture of the Tumour Microenvironment in Rectal Cancer Patients.

Dissemination of Mitochondrial DNA Variants: Looking at the 'Bigger' Picture of the Tumour Microenvironment in Rectal Cancer Patients.

Journal: Journal of extracellular biology

Published: April 09, 2025

CT-guided cryoablation of renal masses.

CT-guided cryoablation of renal masses.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: December 18, 2024

Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis.

Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis.

Journal: Hepatology (Baltimore, Md.)

Published: December 11, 2024

MRI of early rectal cancer; bisacodyl micro-enema increases submucosal width, reader confidence, and tumor conspicuity.

MRI of early rectal cancer; bisacodyl micro-enema increases submucosal width, reader confidence, and tumor conspicuity.

Journal: Abdominal radiology (New York)

Published: September 25, 2024

Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade.

Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade.

Journal: Oncoimmunology

Published: July 02, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026